|
Statement
| 1.Date of occurrence of the change:2022/06/10
2.Elected or changed position (Please enter institutional
director, institutional supervisor, independent director,
natural-person director or natural-person supervisor):
Institutional director, independent director,
natural-person director.
3.Title and name of the previous position holder:
Chairman:
Augusta Inc. Representative: Chung-Hur Lee
Director:
-Lee-Cheng Liu
-Formosa Laboratories, Inc. Representative: Cheng-Yu Cheng
-National Development Fund, Executive Yuan
Representative: Wei-Feng Kao
-Yao-Hwa Glass Co., Ltd, Management Commission
Representative: Wei-Hung Chang
-Taiwania Capital Buffalo II Bioventures, LP
Representative: Chih-Lung Shen
-Development Center for Biotechnology
Representative: Hsiu-Hui Chen
Independent Director:
-Ming-Thaur Chang
-Fu-Shiow Yin
-Ming-Shen Chen
4.Resume of the previous position holder:
Chairman:
Chung-Hur Lee: Chairman, EirGenix, Inc.
Director:
-Lee-Cheng Liu: President & CEO, EirGenix, Inc.
-Cheng-Yu Cheng: Chairman & President, Formosa Laboratories, Inc.
-Wei-Feng Kao: National Development Council,
Department of Industrial Development, Senior Technical Specialist.
-Wei-Hung Chang: Chairman, Meco Technology Co., Ltd.
-Chih-Lung Shen: General Partner, Taiwania Bio Fund.
-Hsiu-Hui Chen: Vice President, Development Center for Biotechnology.
Independent Director:
-Ming-Thaur Chang: Independent Director, DBS Bank (Taiwan) Ltd.
-Fu-Shiow Yin: Independent Director, Foresee Pharmaceuticals Co., Ltd.
-Ming-Shen Chen: Professor of Finance at National Taiwan University.
5.Title and name of the new position holder:
Chairman:
Lee-Cheng Liu
Director:
-Formosa Laboratories, Inc. Representative: Cheng-Yu Cheng
-National Development Fund, Executive Yuan
Representative: Hsiu-Hui Chen
-Yao-Hwa Glass Co., Ltd, Management Commission
-Foxconn Technology Co., Ltd. Representative: Jih-Luh Tang
-Foxconn Technology Co., Ltd. Representative: Hsueh-Yen Ku
Independent Director:
-Ming-Thaur Chang
-Fu-Shiow Yin
-Ming-Shen Chen
-Po-Chih Chen
6.Resume of the new position holder:
Chairman:
Lee-Cheng Liu: President & CEO, EirGenix, Inc.
Director:
-Cheng-Yu Cheng: Chairman & President, Formosa Laboratories, Inc.
-Hsiu-Hui Chen: Vice President, Development Center for Biotechnology.
-Yao-Hwa Glass Co., Ltd, Management Commission:
Director, Adimmune Biotech Corporation.
Director, PharmaEssentia Corporation.
Director, Locus Cell Corporation.
-Jih-Luh Tang: Co-Founder and Chief Medical Officer,
iCare Diagnostics International Co.
-Hsueh-Yen Ku: Board Director and CTO,
iCare Diagnostics International Co. Ltd.
Independent Director:
-Ming-Thaur Chang: Independent Director, DBS Bank (Taiwan) Ltd.
-Fu-Shiow Yin: Independent Director, Foresee Pharmaceuticals Co., Ltd.
-Ming-Shen Chen: Professor of Finance at National Taiwan University.
-Po-Chih Chen: Senior Advisors to the President.
7.Circumstances of change (Please enter "resignation", "dismissal",
"term expired", "death" or "new appointment"): Term expired.
8.Reason for the change:
Term expired and the whole Board is re-elected.
9.Number of shares held by the new position holder when elected:
Chairman:
Lee-Cheng Liu (2,286,884 shares)
Director:
-Formosa Laboratories, Inc. (18,845,818 shares)
Representative: Cheng-Yu Cheng (0 shares)
-National Development Fund, Executive Yuan (15,288,860 shares)
Representative: Hsiu-Hui Chen (0 shares)
-Yao-Hwa Glass Co., Ltd, Management Commission (13,078,082 shares)
-Foxconn Technology Co., Ltd. (27,500,000 shares)
Representative: Jih-Luh Tang (0 shares)
-Foxconn Technology Co., Ltd. (27,500,000 shares)
Representative: Hsueh-Yen Ku (0 shares)
Independent Director:
-Ming-Thaur Chang (0 shares)
-Fu-Shiow Yin (0 shares)
-Ming-Shen Chen (0 shares)
-Po-Chih Chen (0 shares)
10.Original term (from __________ to __________): 2019/06/12~2022/06/11
11.Effective date of the new appointment: 2022/06/10
12.Turnover rate of directors of the same term:
Not applicable. The whole Board is re-elected.
13.Turnover rate of independent directors of the same term:
Not applicable. The whole Board is re-elected.
14.Turnover rate of supervisors of the same term: Not applicable.
15.Change in one-third or more of directors (Please enter "Yes" or
"No"):Yes
16.Any other matters that need to be specified:
Mr.Weng, Ku-Sung, the appointed representative of
Yao-Hwa Glass Co., Ltd, Management Commission.
Resume:Deputy Director, Consumer Goods and Chemical Industries Division,
Industrial Development Bureau Ministry of Economic Affairs.
Number of shares held by the new position holder:0 shares (2022/06/10)
|
